Vilin Bio Med Ratios

Vilin Bio Med Ltd Ratios

The Vilin Bio Med Ltd Ratios page provides a complete fundamental analysis of Vilin Bio Med Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Vilin Bio Med Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Vilin Bio Med Ltd (NSE: VILINBIO, BSE: 78871) is currently trading at ₹36.65, with a market capitalization of ₹521.03M. As a major player in the Health technology sector and Pharmaceuticals: major industry, Vilin Bio Med Ltd remains a key stock for fundamental analysis using Vilin Bio Med Ltd Ratios.

Vilin Bio Med Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Vilin Bio Med Ltd P/E ratio currently stands at 0, making it one of the most tracked metrics in Vilin Bio Med Ltd Ratios.

Historically, the Vilin Bio Med Ltd P/E ratio has shown strong fluctuations:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0

The decline in Vilin Bio Med Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The Vilin Bio Med Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 0.

Historical P/B trend:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0

Vilin Bio Med Ltd shows reasonable valuation compared to its asset base.

Price to Sales Ratio (P/S)

The Vilin Bio Med Ltd P/S ratio currently stands at 0, an important part of Vilin Bio Med Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0

A stable or declining Vilin Bio Med Ltd P/S ratio indicates cautious market sentiment.

Vilin Bio Med Ltd Price to Cash Flow Ratio (P/CF)

The Vilin Bio Med Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 0.

Historical Vilin Bio Med Ltd Price to Cash Flow Ratio:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0

The declining Vilin Bio Med Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Vilin Bio Med Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Vilin Bio Med Ltd EV currently stands at ₹0, representing the total company valuation including debt.

Historical EV trend:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0

Vilin Bio Med Ltd enterprise value consolidation suggests stable valuation.

EV/EBITDA Ratio

The Vilin Bio Med Ltd EV/EBITDA ratio is currently 0, a key metric in Vilin Bio Med Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0

Stable Vilin Bio Med Ltd EV/EBITDA indicates balanced valuation.

Vilin Bio Med Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Vilin Bio Med Ltd D/E ratio is currently 0.11, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0.11
• 2023: 0.30
• 2022: 0.46
• 2021: 0.72

Vilin Bio Med Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Vilin Bio Med Ltd ROE currently stands at 0.97%, showing profitability and capital efficiency.

Historical ROE:

• 2024: 0.97
• 2023: 0.97
• 2022: 13.78
• 2021: 0

Declining ROE indicates pressure on profitability.

Vilin Bio Med Ltd Ratios Analysis Summary

The Vilin Bio Med Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Vilin Bio Med Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Vilin Bio Med Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.